Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
Brendan Le Daré, Christelle Boglione‐Kerrien, Florian Reizine, Jean‐Pierre Gangneux, Astrid Bacle
Abstract
International audience
Topics & Concepts
VoriconazoleMedicineDosingCoronavirus disease 2019 (COVID-19)Intensive care medicinePulmonary aspergillosisAspergillosis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicPersonalized medicineBioinformaticsPathologyInternal medicineOutbreakImmunologyDermatologyInfectious disease (medical specialty)AntifungalBiologyDiseaseAntifungal resistance and susceptibilityBacterial biofilms and quorum sensingFungal Infections and Studies